News

Results Found (507)
November 25, 2020
SavorEat Raises NIS 42.6m in TASE IPO

In the first-ever food-tech Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE), SavorEat (TASE: SVRT) has raised NIS 42.6 million (about $13 million) from leading Israeli institutional investors.

November 17, 2020
ChickP Releases New Product: ChickP Native Starch

ChickP: The new chickpea starch can be used to thicken alternative dairy, as well as plant-based meat analogs, desserts, soups, and baked goods.

November 15, 2020
Yissum CEO discusses what it takes to run an Israeli Start Up

Dr. Itzik Goldwaser talks about his personal journey before becoming the head of Yissum. (Spanish)

August 5, 2020
GemmaCert Analyzes Cannabis Potency in Minutes

GemmaCert a Yissum cannabis-tech spinout, has developed in-house testing solutions to test the active ingredients in cannabis by analyzing total THC and CBD levels throughout the entire supply chain. 

August 2, 2020
Future Meat Technologies & Savor Eat Finalists in Food Innovation Contest

Congratulations to Yissum spinouts Future Meat Technologies and SavorEat for making the finals in the FoodTech Innovation contest sponsored by Calcalist and Tnuva.

July 28, 2020
Yissum Spinouts Raise $79 million in H1 2020 Despite Coronavirus Uncertainty

Startups from The Hebrew University of Jerusalem raised $79 million in the first half of 2020. Despite the continuing global uncertainty caused by the coronavirus and ongoing lockdowns around the world, 14 Yissum spinouts raised tens of millions...

July 27, 2020
Savor Eat Raises $3M to 3D Print Customized Burgers

SavorEat announced a $3M Series A funding round from Meitav Dash following a recent raise of $1.75M in seed funding from Millennium Food Tech. Their goal is to offer personalized burgers tailor-fitted to your preferred taste.

July 23, 2020
Better Juice partners with US companies for sugar-reduction tech

Better Juice teamed up with several U.S.-based global beverage companies to commercialize its sugar-reduction technology.

July 23, 2020
Betalin to Start Human Trials

Yissum subsidiary, Betalin Therapeutics Ltd. has announced that it is ready to start human trials pending approval. It's "bio-artificial” pancreas aims to free patients of the need for insulin injections and blood sugar...

July 15, 2020
Nectin Therapeutics Raises $6M from aMoon Velocity

Nectin Therapeutics, a leading developer of next-generation immuno-oncology bio therapies, raised $6 million with the total expected to reach $15 million. The investment round was led by aMoon Velocity, the early-stage fund of VC aMoon Fund.

May 5, 2020
Hebrew U Reseachers Develop Injection to Fight Superbugs

New treatment, which allows previously topical drug to be administered intravenously, is ‘a game-changer’ in the battle against antibiotic-resistant bacteria. It could have a significant impact on the morbidity rate for pandemics such as...

March 29, 2020
HU Researchers Submit Proposals to IIA to Investigate Covid-19 Treatments

Researchers at The Hebrew University of Jerusalem as well as several Yissum start-up companies are exploring a variety of methods to combat the COVID-19 virus, through investigations into AI drug discovery, biochemical detection tools, and...